slides · global inventory
Table
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 60,568
Current window 42,811-42,840
Pages 2,019
Rows per page 30
Component
42,811-42,840 of 60,568
39
Includes a footnote regarding the exclusion of gains from business disposals in FCF conversion.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · Action1 hit
40
Includes standard GAAP vs non-GAAP reconciliation disclosure language.LKQ | Results Presentation Deck | 40 slides · LKQ
Conference presentation Investor relations Beat · Action1 hit
14
LVMH | Results Presentation Deck | 29 slidesLVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
20
LVMH | Results Presentation Deck | 29 slidesLVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations Beat · SatisfactionLoop · Zoom In1 hit
28
The table displays 60 distinct data points representing organic revenue growth percentages.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations 1 hit
29
The table includes two distinct blocks for 2023 and 2022, showing quarterly, half-year (H1), and nine-month (9M) figures.LVMH | Results Presentation Deck | 29 slides · LVMH
Conference presentation Investor relations 1 hit
14
The table compares Cyramza+Docetaxel, Docetaxel alone, and THIO+Libtayo.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Loop · Pattern Hunter1 hit
15
The slide highlights that THIO has a better safety profile than standard chemotherapy, which typically has 70-80% incidence of Grade 3-5 side effects.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
16
DCR stands for Disease Control Rate. The table compares historical clinical trial data (KEYNOTE 024, REVEL, RWD) against the company's own THIO-101 trial data.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
17
Data presented in a table format with specific clinical definitions for DCR and treatment lines.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
25
The table compares three treatment regimens across four categories: Expected Efficacy, Safety Profile, Administration, and Trial of Reference.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
26
The table compares historical standard of care data against planned THIO-102 trial outcomes.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
27
MAIA Biotechnology | Investor Presentation Deck | 39 slidesMAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
34
Includes details on options, warrants, and insider ownership percentage.MAIA Biotechnology | Investor Presentation Deck | 39 slides · MAIA Biotechnology
Pitch deck Investor relations Beat · Team1 hit
04
The slide uses hub-and-spoke diagrams to visually contrast decentralized vs centralized networks.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
08
The slide presents clinical validation data for the ColoAlert diagnostic test.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
16
Data presented in a summary table and two pie charts showing disease staging distribution.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
25
Includes income statement highlights and balance sheet data.Mainz Biomed NV | Investor Presentation Deck | 27 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
04
The slide uses hub-and-spoke diagrams to visually contrast decentralized vs centralized networks.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
08
The slide presents clinical validation data for the ColoAlert diagnostic test.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
17
The slide provides clinical trial data breakdown for a diagnostic product.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
26
Includes unaudited financial results and balance sheet data.Mainz Biomed NV | Investor Presentation Deck | 28 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
04
The slide presents preliminary financial results for Matson, including income statement components and debt/cash positions.Matson | Results Presentation Deck | 10 slides · Matson
Conference presentation Investor relations Beat · Financials1 hit
05
Includes specific data sources for Hawaii state and Maui economic reports.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · NeedLoop · Cost Of Inaction1 hit
12
Includes GAAP EPS, depreciation, and EBITDA metrics.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
14
Includes a footnote regarding total debt calculation.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · SatisfactionLoop · So What Cascade1 hit
18
Includes two separate tables for three-month and nine-month periods.Matson | Results Presentation Deck | 18 slides · Matson
Conference presentation Investor relations Beat · Action1 hit
04
Includes non-GAAP adjustments and profitability metrics.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
05
Includes footnotes explaining specific line items and the basis of comparison.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit
09
The table compares specific financial ratios (NCOs, Cumulative losses, NPAs, NPLs, ALLL) across three groups.New York Community Bancorp | Results Presentation Deck | 32 slides · New York Community Bancorp
Conference presentation Investor relations Beat · KPI OverviewLoop · Zoom In1 hit